Following this line of evidence, we tested the hypothesis that activation of 5-HT1A receptors could interfere with the release of SP, a neuropeptide documented to be up-regulated and directly involved in IBD-induced intestinal inflammation (Gross and Pothoulakis, 2007). Here, HTR1A is linked to irritable bowel syndrome.